Compound information
- Natural Products
- ZC1782474
- Molecular Formula
- C18H22N4OS
- Molecular Weight
- 342.151432324 g/mol
- Structure
-
- IUPAC Name
- N-(3-methylsulfanylphenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H22N4OS/c1-24-17-6-2-5-16(12-17)20-18(23)22-10-8-21(9-11-22)14-15-4-3-7-19-13-15/h2-7,12-13H,8-11,14H2,1H3,(H,20,23)
- InChI Key
- FVGSNIHJVIZRNB-UHFFFAOYSA-N
- SMILES
- CSc1cccc(NC(=O)N2CCN(Cc3cccnc3)CC2)c1
- Source
- ZINC000013325067
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.257 |
LogS | -3.088 | LogD | 3.186 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.989 | Pgp substrate | 0.888 |
HIA | 0.82 | F20 % | 0.973 |
F30 % | 0.903 | Caco-2 | -5.158 |
MDCK | -5.15 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.835 | PPB | 95.049 |
VD | 1.106 | Fu | 0.934 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.542 | CYP1A2 substrate | 0.793 |
CYP2A6 substrate | 0.795 | CYP2B6 substrate | 0.73 |
CYP2C19 inhibitor | 0.897 | CYP2C19 substrate | 0.932 |
CYP2C8 substrate | 0.851 | CYP2C9 inhibitor | 0.832 |
CYP2C9 substrate | 0.374 | CYP2D6 inhibitor | 0.986 |
CYP2D6 substrate | 0.995 | CYP2E1 substrate | 0.86 |
CYP3A4 inhibitor | 0.472 | CYP3A4 substrate | 0.987 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.76 | CL | 11.673 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.548 | Hepatotoxicity | 0.914 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.838 |
FDAMDD | 0.607 | Skin Sensitization | 0.981 |
Carcinogenicity | 0.048 | Eye Corrosion | 0.001 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.958 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.579 | IGC50 | 3.168 |
LC50FM | 2.84 | LC50DM | -1.462 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.375 | NR-AR-LBD | 0.202 |
NR-AhR | 0.729 | NR-Aromatase | 0.033 |
NR-ER | 0.338 | NR-ER-LBD | 0.318 |
NR-PPAR-gamma | 0.151 | SR-ARE | 0.804 |
SR-ATAD5 | 0.349 | SR-HSE | 0.218 |
SR-MMP | 0.023 | SR-p53 | 0.07 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.